Listed

Kraig Biocraft Laboratories, Inc.: Form 10-K for the period ended Dec 31, 2011

Filed with the SEC on Apr 12, 2012 and accepted by EDGAR at Apr 12, 2012, 17:23 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2011-01-01 to 2011-12-31$250.6kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2011-01-01 to 2011-12-31−$1.3mus-gaap:OperatingIncomeLoss
Net income12 months2011-01-01 to 2011-12-31−$1.3mus-gaap:NetIncomeLoss
Diluted EPS12 months2011-01-01 to 2011-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2011-01-01 to 2011-12-31−$556.1kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-01-01 to 2011-12-31$1.2kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2011-12-31$195.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-12-31$201.4kus-gaap:AssetsCurrent
Total assetsAt period end2011-12-31$223.5kus-gaap:Assets
Current liabilitiesAt period end2011-12-31$1.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-12-31$1.1mus-gaap:Liabilities
Shareholders' equityAt period end2011-12-31−$906.5kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-12-001819. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.